Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C15H18N6O.2ClH |
| Molecular Weight | 371.265 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.Cl.O=C(CNCCNC1=CC=C(C=N1)C#N)N2CCC[C@H]2C#N
InChI
InChIKey=VNACOBVZDCLAEV-GXKRWWSZSA-N
InChI=1S/C15H18N6O.2ClH/c16-8-12-3-4-14(20-10-12)19-6-5-18-11-15(22)21-7-1-2-13(21)9-17;;/h3-4,10,13,18H,1-2,5-7,11H2,(H,19,20);2*1H/t13-;;/m0../s1
| Molecular Formula | C15H18N6O |
| Molecular Weight | 298.343 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL284 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10512614 |
11.0 nM [Ki] | ||
Target ID: CHEMBL284 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10512614 |
11.0 nM [Ki] |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:19:30 GMT 2025
by
admin
on
Mon Mar 31 18:19:30 GMT 2025
|
| Record UNII |
PWKTKAMJUR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9799555
Created by
admin on Mon Mar 31 18:19:30 GMT 2025 , Edited by admin on Mon Mar 31 18:19:30 GMT 2025
|
PRIMARY | |||
|
PWKTKAMJUR
Created by
admin on Mon Mar 31 18:19:30 GMT 2025 , Edited by admin on Mon Mar 31 18:19:30 GMT 2025
|
PRIMARY | |||
|
207556-62-5
Created by
admin on Mon Mar 31 18:19:30 GMT 2025 , Edited by admin on Mon Mar 31 18:19:30 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Potent, orally active dipeptidyl peptidase (DPP)-IV inhibitor (Ki = 11 nM, IC50 = 14 nM) that displays > 15 000-fold selectivity over DPP-II and a range of proline-cleaving proteases. Exhibits antidiabetic activity in vivo improves glucose tolerance, increases glucagon-like peptide 1 (GLP-1) and insulin levels, augments insulin secretion and GLUT2 levels, and reduces (preserves) islet size.
|